SCHEMBL135663

SCHEMBL135663

COc1cccc(CC(=O)c2c(N)sc3c2CCCC3)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.65
MAPT P10636 10/20 0.55
TP53 P04637 2/20 0.55
LMNA P02545 2/20 0.55
NPC1 O15118 1/20 0.53
POLB P06746 1/20 0.53
ALDH1A1 P00352 7/20 0.52
TAAR1 Q96RJ0 2/20 0.52
FLT3 P36888 1/20 0.52
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
HPGD P15428 5/20 0.50
ALOX15 P16050 5/20 0.50
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 4/20 0.50
THRB P10828 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NOD1 Q9Y239 1/20 0.50
GAA P10253 2/20 0.49
ALOX12 P18054 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134641 0.86 FLT3 (0.53) MAPTTP53LMNAALDH1A1FLT3
SCHEMBL135664 0.81 ALDH1A1 (0.73) RXFP1MAPTLMNANPC1ALDH1A1
SCHEMBL8289500 0.79 RXFP1 (1.00) RXFP1MAPTTP53LMNAFLT3
SCHEMBL8288681 0.78 RXFP1 (0.98) RXFP1MAPTTP53LMNAFLT3
SCHEMBL31502646 0.74 MAPT (0.65) MAPTTP53NPC1POLBALDH1A1
SCHEMBL4060800 0.73 TDP1 (0.71) MAPTLMNAALDH1A1FLT3MEN1
SCHEMBL31502665 0.72 GAA (0.59) MAPTTP53LMNAPOLBALDH1A1
SCHEMBL20128476 0.72 ALDH1A1 (0.66) MAPTLMNAALDH1A1FLT3MEN1
SCHEMBL4380481 0.71 MAPT (0.66) RXFP1MAPTTP53LMNANPC1
SCHEMBL134640 0.70 MEN1 (0.67) MAPTLMNAALDH1A1FLT3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS RXFP1 4822/4885MAPT 2061/4885TP53 3027/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS RXFP1 4822/4885MAPT 2061/4885TP53 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.